As a reference standard, the presence of SARS-CoV-2 S1-specific IgM and IgG in positive controls were verified with an in-house Luminex-based COVID-19 assay (Magpix technology, Luminex Corporation) [8]. This evidence concerns the gene CD40LG and COVID-19.